Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ('Adial” or the 'Company”), a clinical-stage biopharmaceutical company focused on ...

Researchers in China validated the updated SOFA-2 score specifically in sepsis using data from a multicenter randomized trial ...

The incidence of severe maternal morbidity remains high among patients with sickle cell disease, but a novel risk calculator ...

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for ...

BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue derived products for advanced wound care, today ...

Planet Money went to the annual meeting of the American Economics Association, and we saw some fascinating papers presented ...

The Supreme Court today(January 30) held that offering Stem Cell Treatment(SCT) therapy as a clinical service for curing ...

CSR, NTST, AKR, and COLD have high short interest, strong profitability, and no clear negative catalysts, making them prime ...

Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives January 28, 2026 4:00 PM ...

Doctors are finding new hope for people at risk of losing their sight from age-related macular degeneration, or AMD. Research from the University of Liverpool suggests that metformin, a long-used ...

The budget increased the capex allocation to certain sectors to sustain and accelerate economic growth.

Subcutaneous Saphnelo may offer people with lupus more convenient dosing with efficacy similar to the approved infusion version of the therapy, data show.